Replies to post #41618 on OncoSec Medical Inc (ONCSQ)

[Titan V]

Thanks for your insights as always hschlauch! I found this on Nature:

FOXP3+ regulatory T cells and their functional regulation
https://www.nature.com/articles/cmi201510

Looking forward to Dan unlocking OncoSec’s value in coming months using his past relationships with big pharmas.

[Titan V]

Other than targeting refractory patients to checkpoint inhibitors, do you think ONCS has a shot as a first line combination therapy in the future? Is it too early to determine/talk about that?